Texas Department of State Health Services 
Funding Information Center Toll free: 1-888-963-7111 ext. 7684 Austin phone: (512) 776-7684 Fax: (512) 776-7683
The Texas Department of State Health Services Funding Alert is published weekly. If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://webds.dshs.state.tx.us/fic/subscribe.htm. Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.
Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.
Funding News and Grant Tips
Early Bird Registration Opens for 2013 Texas Nonprofit Summit
OneStar Foundation and Greenlights are proud to present the 2013 Texas Nonprofit Summit on Thursday, September 12 from 8am to 5pm and on Friday, September 13 from 8am to 12pm in Austin.
Join more than 700 nonprofit professionals, board members, funders, government representatives and other community leaders to experience an energizing two days of learning, networking and sharing of ideas and resources. Learn about nonprofit trends, innovative theories and practices, and get to know nonprofit leaders from across Texas and beyond. Register today to ensure your spot at Texas' premiere nonprofit conference!
For a Summit agenda, list of speakers, information about hotel accommodations, parking, and other conference details, please visit http://www.texasnonprofitsummit.org.
If you have a question that the website doesn’t answer, please contact Alanna Fraase at alannaf@greenlights.org or 512-477-5955 ext. 271.
Early Bird rates are limited to the first 250 registrants or until June 1, whichever comes first (regular rates are $235 Greenlights members or OneStar grantees and $280 for nonmembers/grantees).
To register go to https://greenlights.secure.force.com/apex/register?cid=a0uC0000009jmpBIAQ.
From Greenlights for Nonprofit Success Web site, accessed 11/8/12
Nonprofits Face Challenges Accessing Corporate Funders
A survey of corporate funders in Massachusetts provides some lessons for nonprofits nationwide.
The report finds that 1) companies want a more "hands-on" role in charitable missions, and 2) nonprofits which offer social services, compared to, say, education and the arts, face the toughest time in soliciting corporate support.
According to the survey released jointly by the Massachusetts Nonprofit Network and Natixis Global Asset Management, "human service organizations can benefit from the time, talent and treasure of the private sector. It is critical, however, that they understand that strong corporate engagement must be based on real partnership, not just checkbook philanthropy."
The key, according to the survey, is to find creative ways to stand out from other organizations.
Trouble spots...
The challenge is particularly daunting for nonprofit human service agencies, which need creative ways to stand out amidst competition from larger arts and cultural organizations.
More than half of the 103 Massachusetts nonprofits surveyed said they were "least effective" in making "initial contact" with potential business partners and identified that as the most difficult part of getting support from the business community.
Even after contact is made, more than 35 percent of survey respondents rated "identifying how businesses will benefit from partnering with my organization" as one of the things at which they are least effective. "Human service organizations can benefit from the time, talent and treasure of the private sector. It is critical, however, that they understand that strong corporate engagement must be based on real partnership, not just checkbook philanthropy," according to the study.
Best bets...
More than 85 percent of the nonprofits surveyed received some support from financial services, banking and insurance companies.
The other most common sources of corporate support were health care companies and the construction and development industry.
From Community Health Funding Report, 11/2/12
Public Funding Opportunities
Alzheimer's Disease Therapeutics Program (U01): RFA-AG-13-014
SOURCE: National Institute on Aging (NIA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Neurological Disorders and Stroke (NINDS)
APPLICATION DEADLINE: Letter of Intent: 12/14/12. Application: 1/14/13.
$ AVAILABLE: NIH intends to commit up to a total of $1 million for FY 2013; to fund up to five awards in FY 2013. In addition, in FY 2013 NIH intends to commit up to a total of $3 million in in-kind drug development services. Awards issued under this announcement are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The goal of this Funding Opportunity Announcement (FOA) is to provide support for investigators to develop new drugs for the prevention or treatment of Alzheimer’s disease (AD). Specifically, this initiative is aimed at researchers who have promising small molecule compounds but lack outside drug development expertise and infrastructure support to advance these compounds to the clinic. This Alzheimer’s Disease Therapeutics Program adjunct to the NIH Blueprint Neurotherapeutics Program will allow investigators access to a “virtual pharma” network of contract research organizations, technical and regulatory experts and project managers, with extensive biopharma-industry experience. The long-term goal of the Alzheimer’s Disease Therapeutics Program is to advance projects from medicinal chemistry optimization through Phase l clinical trials and facilitate industry partnership for their further development.
CFDA: 93.866, 93.273, 93.853
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-13-014.html
From NIH Web site, accessed 11/7/12
Subject(s) medical research
AmeriCorps State and National Grants
SOURCE: Corporation for National and Community Service (CNCS)
APPLICATION DEADLINE: 1/23/13.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Entities eligible to apply include:
* Public or private nonprofit organizations, including labor organizations.
* Faith-based and other community organizations.
* Institutions of higher education.
* Government entities within states or territories (e.g., cities, counties).
* Indian tribes.
* Partnerships and consortia.
* Intermediaries planning to subgrant funds awarded.
The Corporation encourages organizations that have never received funding from the Corporation or AmeriCorps to apply.
PURPOSE: AmeriCorps awards grants to organizations to implement programs that utilize AmeriCorps members to engage in evidence-based interventions to strengthen communities.
CFDA: 94.006
CONTACT: For questions regarding multi-state or Indian tribes applications submitted directly to CNCS: (202) 606-7508, e-mail: americorpsgrants@cns.gov.
For questions regarding state-level funding contact your state commission. A list of state commissions is available at http://www.americorps.gov/about/contact/statecommission.asp.
From Rural Assistance Center Web site, accessed 11/8/12
Subject(s) community health services
Bridging the Gap: Early Translational Research Awards: RFA R-13-ETRA-1
SOURCE: Cancer Prevention and Research Institute of Texas (CPRIT)
APPLICATION DEADLINE: 12/14/12.
$ AVAILABLE: Applicants may request a maximum of $1,000,000 in total costs over a period of one to three years.
ELIGIBILITY: The applicant must be a Texas-based entity. Any not-for-profit institution that conducts research is eligible to apply for funding under this award mechanism. A public or private company is not eligible for funding under this award mechanism; these entities must use the appropriate award mechanism(s) under CPRIT’s Commercialization Program.
PURPOSE: This Request for Applications (RFA) solicits applications for innovative research projects addressing critically important questions that will significantly advance the treatment of cancer. The objective of this award is to “bridge the gap” between promising new discoveries achieved in the research laboratory and commercial development by funding attainment of a Target Product Profile (See Section 3, Mechanism of Support) for the therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario.
CFDA: none
CONTACT: HelpDesk support is available for questions regarding user registration and online submission of applications. Telephone: (866) 941-7146, e-mail: Help@CPRITGrants.org. For more information see http://www.cprit.state.tx.us/images/uploads/rfa_r-13-etra-1.pdf
From CPRIT e-mail, 11/5/12
Subject(s) cancer research
Collaborative Network for Clinical Research on Immune Tolerance (UM1): RFA-AI-12-043
SOURCE: National Institute of Allergy and Infectious Diseases (NIAID)
APPLICATION DEADLINE: Letter of Intent: 2/7/13. Application: 3/7/13.
$ AVAILABLE: NIAID intends to commit $27 million in FY 2014.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this announcement is to solicit applications for the Collaborative Network for Clinical Research on Immune Tolerance. The major goal of this Network is to develop new tolerogenic approaches for the treatment and prevention of disease in three clinical areas: asthma and allergic diseases; autoimmune diseases; and immune-mediated rejection of transplanted solid organs, tissues and cells. The scope of research to be carried out includes: 1) the design and conduct of clinical trials at all phases to evaluate the safety and efficacy of investigational products and approaches for the induction and maintenance of immune tolerance in humans; 2) the design and conduct of mechanistic studies and the development of tolerance assays as integral components of the clinical trials undertaken, including establishing and directing a consortium of laboratories; and 3) the provision of bioinformatics, data collection, validation and analysis resources. In addition, on a limited basis, the Network may support focused product development and nonclinical studies (e.g., toxicology, pharmacology, pharmacokinetics, etc.) essential for the subsequent evaluation of promising tolerance induction approaches in humans.
CFDA: 93.855, 93.856
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-043.html
From NIH Web site, accessed 11/7/12
Subject(s) medical research
Developmental Centers for Interdisciplinary Research in Benign Urology (P20): RFA-DK-12-022
SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICATION DEADLINE: Letter of Intent: 1/25/13. Application: 2/27/13.
$ AVAILABLE: The NIDDK intends to commit $1 million in FY 2013 to support three to four centers.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for the Developmental Centers for Interdisciplinary Research in Benign Urology Program (P20). The intent of this Program is to build research teams capable of developing new research projects that take an integrative approach towards addressing problems in benign urology. Each Developmental Center is limited to a single Scientific Project and must contain an Administrative Core and an Educational Enrichment Program. The Developmental Centers Program will work closely with the George M. O’Brien Urology Cooperative Research Centers Program (U54) (RFA-DK-12-009).
CFDA: 93.847
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-022.html
From NIH Web site, accessed 11/7/12
Subject(s) medical research, diabetes
Notice of Open Enrollment for Newborn Screening Benefits (NBS): SHS/NBS-0525.1
SOURCE: Department of State Health Services (DSHS)
APPLICATION DEADLINE: 8/31/18.
$ AVAILABLE: This contract may be renewed up to 5 additional one year period(s), with renewal initiated at the sole discretion of DSHS. Continued renewal of the contract in future years is contingent upon the availability of funds and the satisfactory performance of the contractor during the prior contract period. Pricing may vary and is subject to change each renewal.
ELIGIBILITY: Eligible applicants include Texas medical providers, who are currently enrolled as Medicaid Providers, certified laboratories that provide confirmatory testing and follow-up testing for disorders identified through the DSHS NBS Program, pharmacies that provide medications, vitamins, and dietary supplements prescribed by health care providers specializing in metabolic, endocrine, and hematologic disorders, necessary for treatment and management of diagnosed disorders, and manufactures or retailers of low-protein foods that are specially formulated and intended for the dietary management of a disorder identified by the DSHS NBS Program for individuals with distinctive nutritional needs that cannot be met by normal diet alone.
PURPOSE: The Department of State Health Services (DSHS) Newborn Screening (NBS) Unit announces this notice of Open Enrollment (OE) requesting applications from eligible applicants to provide services to eligible clients in accordance with the Newborn Screening (NBS) Program rules, 25 Texas Administrative Code (TAC) §§37.51-37.65. This OE is not limited to this source of funding if other sources become available for this Project.
CFDA: none
CONTACT: Bill Walk, (512) 458-7470, e-mail: bill.walk@dshs.state.tx.us. For more information see http://esbd.cpa.state.tx.us/bid_show.cfm?bidid=100995
From Electronic State Business Daily Web site, accessed 11/8/12
Subject(s) children's health
Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiation (SBIR [R43]): RFA-ES-13-003
SOURCE: National Institute of Environmental Health Sciences (NIEHS)
APPLICATION DEADLINE: Letter of Intent: 1/14/13. Application: 2/13/13.
$ AVAILABLE: NIEHS intends to fund an estimate of eight to 10 awards, corresponding to a total of $2.5 million for fiscal year 2013.
ELIGIBILITY: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
PURPOSE: This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop medium- to high-throughput assays to evaluate the effects of toxicants on pluripotent or induced pluripotent cells with respect to cell differentiation and the resulting differentiated cell populations. The ability to incorporate genetic diversity in these assays would be useful. These assays will provide information on mechanisms of chemically-induced biological activity, help to prioritize chemicals for more extensive toxicological evaluation, support more predictive models of in vivo biological response, and potentially inform on the role of genetic diversity in toxicological effects.
CFDA: 93.113
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-13-003.html
From NIH Web site, accessed 11/7/12
Subject(s) medical research, technology
Substance Abuse Intervention Programs: SA/INTV-540.1
SOURCE: Department of State Health Services (DSHS)
APPLICATION DEADLINE: 12/12/12.
$ AVAILABLE: Approximately $10 million is expected to be available to fund multiple contracts.
ELIGIBILITY: Eligible respondents include public and private nonprofit entities and governmental entities and must comply with the criteria listed in the complete URL. For-profit entities are not eligible to apply for funds under this RFP.
PURPOSE: The Department of State Health Services (DSHS) Mental Health and Substance Abuse Division announces the expected availability of State Fiscal Year (FY) 2014 grant funds to provide substance abuse intervention services (Project). This Request for Proposal (RFP) is not limited to this source of funding if other sources become available for this Project. Services are being procured in all Health and Human Services (HHSC) Regions of the state. If respondent is proposing services in multiple Regions, a complete and separate RFP is required for each Region. Respondents may apply for one or more of the program types. The following program types for this RFP are: a. Rural Border Intervention (RBI) b. Pregnant and Postpartum Intervention (PPI) c. Human Immunodeficiency Virus (HIV) Early Intervention (HEI) d. HIV Outreach Services (HIV) The purpose of the RBI program is to provide distinct but integrated prevention and intervention services that address the specific needs of the rural border communities and to provide access to a continuum of behavioral health services, including substance abuse prevention, intervention, and treatment, and mental health promotion and treatment to members of the rural border community who have or are at high risk of developing substance use disorders. The purpose of the PPI program is to provide community-based, gender-specific outreach and intervention services for pregnant and postpartum females (adult and youth) with substance use disorders or who are at risk of developing substance use disorders. The purpose of the HEI program is to provide comprehensive case management, service coordination, education on communicable diseases, support for disease management and recovery from substance abuse and dependence to persons with both HIV infection and substance abuse or dependence and their families and significant others. The purpose of the HIV program is to provide targeted outreach services that inform individuals who abuse substances about the relationship between drug use, HIV and other communicable diseases, including hepatitis C and tuberculosis (TB) using evidence-based and culturally competent intervention.
CFDA: none
CONTACT: Jeanne Rosenkrans, (512) 458-7470, e-mail: Jeanne.Rosenkrans@dshs.state.tx.us. For more information see http://esbd.cpa.state.tx.us/bid_show.cfm?bidid=103176
From Electronic State Business Daily Web site, accessed 11/8/12
Subject(s) substance abuse education/prevention, substance abuse treatment, mental health
Tuberculosis Research Units (U19): RFA-AI-12-045
SOURCE: National Institute of Allergy and Infectious Diseases (NIAID)
APPLICATION DEADLINE: Letter of Intent: 1/14/13. Application: 2/13/13.
$ AVAILABLE: NIAID intends to commit $10 million in FY 2014 to fund two to three awards.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this announcement is to support the establishment of two to three multinational, multidisciplinary Tuberculosis Research Units (TBRUs) that will operate as a collaborative network to study tuberculosis latency and persistence and their relation to active TB disease, in humans and animal models.
CFDA: 93.855; 93.856
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-045.html
From NIH Web site, accessed 11/7/12
Subject(s) medical research
Private Funding Opportunities
CIGNA Foundation Grants
SOURCE: CIGNA Foundation
APPLICATION DEADLINE: Applications accepted on an ongoing basis.
$ AVAILABLE: Although there are no restrictions on amount of funds requested, $5000 is considered a typical grant, particularly for first-time recipients.
ELIGIBILITY: Please note that while there are no geographic restrictions, preference is given to those locations where CIGNA has a significant presence. All organizations requesting funding must be current 501(c)(3) public charities. See Program web site for Grant Disqualifiers.
PURPOSE: Funding for programs that enhance the health of individuals and families and the well-being of communities.
The CIGNA Foundation defines its activities in terms of four primary impact areas. Potential grantees will be expected to demonstrate how their activities positively impact one of these areas.
* Promoting Wellness: Building awareness, helping people manage their health challenges and making health services available and affordable for all.
* Expanding Opportunities: Reaching across barriers – be they based on gender, ethnicity or physical condition – to tap the talents of every person.
* Developing Leaders: Supporting the type of community service that gives talented individuals the experience to become future leaders.
* Embracing Communities: Connecting neighbors to create networks that will address the complex social and environmental challenges we all face.
CONTACT: Grant helpline: (866) 865-5277. For more information see http://www.raconline.org/funding/details.php?funding_id=2127
From Rural Assistance Center Web site, accessed 11/8/12
Subject(s) community health services, health promotion/wellness
Events
Board Essentials
SPONSOR: Greenlights for Nonprofit Success
WHEN: December 4, 11:30 am to 1:30 pm.
WHERE: Greenlights for Nonprofit Success, 7703 N. Lamar Blvd., Suite 400, (Austin, TX).
DESCRIPTION: This workshop provides the fundamental principles and best practices that every nonprofit board member…and the staff who work with them…should know.
Grab a lunch and join us to learn the top 10 roles and responsibilities of board members, with special emphasis on the board’s role in financial oversight, fundraising, planning, and partnering with the organization’s executive leader. You’ll come away with a clear understanding of the many roles that are required of the board and how to recruit and manage great board members.
COST: $20 members / $40 non-members.
CONTACT: If you have any questions, call (512) 477-5955 ext. 252.
From Greenlights for Nonprofit Success Web site, accessed 11/8/12
Building Strategic Alliances: Collaboration, Shared Services, and Mergers
SPONSOR: Greenlights for Nonprofit Success
WHEN: December 6, 1 to 4:30 pm.
WHERE: Greenlights for Nonprofit Success, 7703 N. Lamar Blvd., Suite 400, (Austin, TX).
DESCRIPTION: The Austin area has recently witnessed several successful mergers and collaborations (e.g. AMOA-Arthouse, Catholic Charities-Marywood, One Voice, etc.), and Greenlights is proud to have been involved in many of them.
The concept of “strategic collaboration” where nonprofits leverage the power of working together in one of many potential alliance forms (up to and including outright merger) has become increasingly popular because of its ability to expand our resources and our reach. And funders are increasingly expecting nonprofits to embrace collaboration in meaningful ways.
Join Greenlights to explore strategic alliance-building, from simple coordination of activities, to sharing services such as administrative staff and office space, to all-out formal mergers of organizations. Learn to critically evaluate your collaborative relationships, hear examples of collaborations that work, and develop a plan for enhancing your organization’s capacity and resources through strategic alliance-building.
COST: $55 members / $95 non-members.
CONTACT: If you have any questions, call (512) 477-5955 ext. 252.
From Greenlights for Nonprofit Success Web site, accessed 11/8/12
Return to Alert